111 related articles for article (PubMed ID: 8931974)
1. Association of nm23 protein levels in human prostates with proliferating cell nuclear antigen expression at autopsy.
Igawa M; Urakami S; Shiina H; Ishibe T; Usui T; Chodak GW
Eur Urol; 1996; 30(3):383-7. PubMed ID: 8931974
[TBL] [Abstract][Full Text] [Related]
2. High levels of nm23 expression are related to cell proliferation in human prostate cancer.
Igawa M; Rukstalis DB; Tanabe T; Chodak GW
Cancer Res; 1994 Mar; 54(5):1313-8. PubMed ID: 8118821
[TBL] [Abstract][Full Text] [Related]
3. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.
Konishi N; Nakaoka S; Tsuzuki T; Matsumoto K; Kitahori Y; Hiasa Y; Urano T; Shiku H
Jpn J Cancer Res; 1993 Oct; 84(10):1050-4. PubMed ID: 7693635
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma.
Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Shirakawa H; Ishibe T; Shirakawa R; Nagasaki M; Shirane T; Usui T
Prostate; 1997 Jun; 32(1):49-58. PubMed ID: 9207957
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate.
Jensen SL; Wood DP; Banks ER; Veron M; Lascu I; McRoberts JW; Rangnekar VM
World J Urol; 1996; 14 Suppl 1():S21-5. PubMed ID: 8738406
[TBL] [Abstract][Full Text] [Related]
7. Relationship of serum testosterone level with proliferating cell nuclear antigen and nm23 protein in human prostatic carcinoma tissue.
Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Yagi H; Shirakawa R; Nagasaki M
Oncology; 1997; 54(6):482-9. PubMed ID: 9394845
[TBL] [Abstract][Full Text] [Related]
8. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
9. The abundance of NM23-H1 mRNA is related with in situ microenvironment and intrahepatic metastasis in hepato-cellular carcinoma.
Zheng XY; Ling ZY; Tang ZY; Liu YK; Feng XL; Zhuang W
J Exp Clin Cancer Res; 1998 Sep; 17(3):337-41. PubMed ID: 9894772
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Br J Urol; 1995 Dec; 76(6):708-13. PubMed ID: 8535713
[TBL] [Abstract][Full Text] [Related]
11. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
Lee CS; Redshaw A; Boag G
Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
[TBL] [Abstract][Full Text] [Related]
12. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
13. [Pathological study on the expression of cell adhesion molecules and metastasis suppressor gene in thyroid follicular carcinoma and papillary carcinoma].
Liu Y; Jiang C; Tan Y
Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):322-6. PubMed ID: 12417089
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of nm23-H1 gene product in node-positive lung cancer and lymph nodes.
Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
Lung Cancer; 1999 Apr; 24(1):11-6. PubMed ID: 10403689
[TBL] [Abstract][Full Text] [Related]
15. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.
Lindmark G
Br J Cancer; 1996 Nov; 74(9):1413-8. PubMed ID: 8912537
[TBL] [Abstract][Full Text] [Related]
16. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of nm23-H1 in the human placenta.
Okamoto T; Iwase K; Niu R
Arch Gynecol Obstet; 2002 Jan; 266(1):1-4. PubMed ID: 11998956
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity.
Lee HY; Lee H
Cancer Lett; 1999 Oct; 145(1-2):93-9. PubMed ID: 10530775
[TBL] [Abstract][Full Text] [Related]
19. Expression of nm23-H1 gene product in mediastinal lymph nodes from lung cancer patients.
Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
Eur J Cardiothorac Surg; 2001 Jun; 19(6):904-7. PubMed ID: 11404150
[TBL] [Abstract][Full Text] [Related]
20. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]